Wall Street dips on concerns over fading stimulus, virus fears By Reuters

© Reuters. The New York Stock Exchange is pictured

By Shivani Kumaresan and Medha Singh

(Reuters) – Wall Street’s main indexes dipped on Friday as fears grew over fading stimulus and the blow to the economy from increasing coronavirus infections.

U.S. Treasury Secretary Steven Mnuchin on Friday defended his decision to end several of the Federal Reserve’s key pandemic lending programs on Dec. 31, saying Congress should use the money to help small U.S. companies with grants instead.

The decision to end the program, which was deemed essential by the central bank, comes as data showed a rise in jobless claims last week as new business restrictions to control spiraling COVID-19 infections likely unleashed a fresh wave of layoffs.

California and Ohio imposed nightly curfews on Thursday, joining 20 U.S. states to have adopted new mandates this month to fight the spread of the virus.

“I don’t think we will go through a full-blown contraction or a complete shutdown, but as the vaccine starts to roll out there is potential for tremendous economic improvement next year,” said Scott Brown, chief economist at Raymond James in St. Petersburg, Florida.

U.S. Senate Democratic leader Chuck Schumer and Republican Majority Leader Mitch McConnell decided to resume COVID-19 relief talks on Thursday.

The and the Dow were little changed over this week following two strong weeks of gains, as investors juggled between growing optimism over an effective coronavirus vaccine and near-term economic damage from the surging COVID-19 infections.

Major banks have upgraded their stock market forecasts for 2021 after recent promising data from COVID-19 vaccine trials.

At 09:45 a.m. ET the fell 37.28 points, or 0.13% to 29,445.95, the lost 2.00 points, or 0.06% to 3,579.87 and the lost 9.78 points, or 0.08% to 11,894.94.

All major S&P sectors slipped, barring utilities.

Pfizer Inc (NYSE:) rose 1.8% as the company said it has applied to U.S. health regulators for emergency use authorization of its COVID-19 vaccine.

Apparel and home fashion retailer Ross Stores Inc (NASDAQ:) gained 2% after its quarterly sales topped expectations.

Gilead Sciences Inc (NASDAQ:) fell 1% as a World Health Organization panel advised against the use of remdesivir for patients hospitalized with COVID-19, saying there was no evidence the drug improves survival or reduces the need for ventilation.

Declining issues matched advancing ones on the NYSE, and on the Nasdaq a 0.7-to-1 ratio favored decliners.

The S&P 500 posted nine new 52-week highs and no new low, while the recorded 65 new highs and four new lows.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*